Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study.

ABSTRACT:

SUBMITTER: Chai M 

PROVIDER: S-EPMC10309505 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature